427 related articles for article (PubMed ID: 12505426)
1. Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain.
Rohn TT; Rissman RA; Davis MC; Kim YE; Cotman CW; Head E
Neurobiol Dis; 2002 Nov; 11(2):341-54. PubMed ID: 12505426
[TBL] [Abstract][Full Text] [Related]
2. Activation of caspase-8 in the Alzheimer's disease brain.
Rohn TT; Head E; Nesse WH; Cotman CW; Cribbs DH
Neurobiol Dis; 2001 Dec; 8(6):1006-16. PubMed ID: 11741396
[TBL] [Abstract][Full Text] [Related]
3. Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease.
Rohn TT; Head E; Su JH; Anderson AJ; Bahr BA; Cotman CW; Cribbs DH
Am J Pathol; 2001 Jan; 158(1):189-98. PubMed ID: 11141492
[TBL] [Abstract][Full Text] [Related]
4. Activation of caspase-6 in aging and mild cognitive impairment.
Albrecht S; Bourdeau M; Bennett D; Mufson EJ; Bhattacharjee M; LeBlanc AC
Am J Pathol; 2007 Apr; 170(4):1200-9. PubMed ID: 17392160
[TBL] [Abstract][Full Text] [Related]
5. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease.
Guo H; Albrecht S; Bourdeau M; Petzke T; Bergeron C; LeBlanc AC
Am J Pathol; 2004 Aug; 165(2):523-31. PubMed ID: 15277226
[TBL] [Abstract][Full Text] [Related]
6. Caspase-Cleaved Tau Co-Localizes with Early Tangle Markers in the Human Vascular Dementia Brain.
Day RJ; Mason MJ; Thomas C; Poon WW; Rohn TT
PLoS One; 2015; 10(7):e0132637. PubMed ID: 26161867
[TBL] [Abstract][Full Text] [Related]
7. Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease.
Gamblin TC; Chen F; Zambrano A; Abraha A; Lagalwar S; Guillozet AL; Lu M; Fu Y; Garcia-Sierra F; LaPointe N; Miller R; Berry RW; Binder LI; Cryns VL
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):10032-7. PubMed ID: 12888622
[TBL] [Abstract][Full Text] [Related]
8. Beta-amyloid deposition and neurofibrillary tangle association with caspase activation in Down syndrome.
Head E; Lott IT; Cribbs DH; Cotman CW; Rohn TT
Neurosci Lett; 2002 Sep; 330(1):99-103. PubMed ID: 12213643
[TBL] [Abstract][Full Text] [Related]
9. Accumulation of caspase cleaved amyloid precursor protein represents an early neurodegenerative event in aging and in Alzheimer's disease.
Zhao M; Su J; Head E; Cotman CW
Neurobiol Dis; 2003 Dec; 14(3):391-403. PubMed ID: 14678756
[TBL] [Abstract][Full Text] [Related]
10. The role of caspase cleavage of tau in Alzheimer disease neuropathology.
Cotman CW; Poon WW; Rissman RA; Blurton-Jones M
J Neuropathol Exp Neurol; 2005 Feb; 64(2):104-12. PubMed ID: 15751224
[TBL] [Abstract][Full Text] [Related]
11. Pseudophosphorylation of tau at serine 422 inhibits caspase cleavage: in vitro evidence and implications for tangle formation in vivo.
Guillozet-Bongaarts AL; Cahill ME; Cryns VL; Reynolds MR; Berry RW; Binder LI
J Neurochem; 2006 May; 97(4):1005-14. PubMed ID: 16606369
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease.
Mizukami K; Akatsu H; Abrahamson EE; Mi Z; Ikonomovic MD
Neuropathology; 2016 Apr; 36(2):135-45. PubMed ID: 26293308
[TBL] [Abstract][Full Text] [Related]
13. In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease.
Selznick LA; Holtzman DM; Han BH; Gökden M; Srinivasan AN; Johnson EM; Roth KA
J Neuropathol Exp Neurol; 1999 Sep; 58(9):1020-6. PubMed ID: 10499444
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of phosphorylated translation initiation factor 2 alpha in Alzheimer's disease and Creutzfeldt-Jakob's disease.
Ferrer I
Neuropathol Appl Neurobiol; 2002 Dec; 28(6):441-51. PubMed ID: 12445160
[TBL] [Abstract][Full Text] [Related]
15. Both N-terminal and C-terminal fragments of presenilin 1 colocalize with neurofibrillary tangles in neurons and dystrophic neurites of senile plaques in Alzheimer's disease.
Chui DH; Shirotani K; Tanahashi H; Akiyama H; Ozawa K; Kunishita T; Takahashi K; Makifuchi T; Tabira T
J Neurosci Res; 1998 Jul; 53(1):99-106. PubMed ID: 9670996
[TBL] [Abstract][Full Text] [Related]
16. Caspase-cleaved TAR DNA-binding protein-43 is a major pathological finding in Alzheimer's disease.
Rohn TT
Brain Res; 2008 Sep; 1228():189-98. PubMed ID: 18634762
[TBL] [Abstract][Full Text] [Related]
17. Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology.
Su JH; Zhao M; Anderson AJ; Srinivasan A; Cotman CW
Brain Res; 2001 Apr; 898(2):350-7. PubMed ID: 11306022
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
Ferrer I; Blanco R; Carmona M; Puig B
J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
[TBL] [Abstract][Full Text] [Related]
19. Caspase-mediated cleavage of glial fibrillary acidic protein within degenerating astrocytes of the Alzheimer's disease brain.
Mouser PE; Head E; Ha KH; Rohn TT
Am J Pathol; 2006 Mar; 168(3):936-46. PubMed ID: 16507909
[TBL] [Abstract][Full Text] [Related]
20. Active c-jun N-terminal kinase induces caspase cleavage of tau and additional phosphorylation by GSK-3beta is required for tau aggregation.
Sahara N; Murayama M; Lee B; Park JM; Lagalwar S; Binder LI; Takashima A
Eur J Neurosci; 2008 Jun; 27(11):2897-906. PubMed ID: 18540881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
